Tuazon, Noriel T.
HRN: 21-78-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFUROXIME 1.5GM (VIAL)
08/18/2022
08/25/2022
IV
1.5g
Q8
For Prophylaxis Surgical
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Duration Wrong Duration
Overall appropriateness: No Wrong Duration